Citations

Showing 10 of 108104 citations.

Positive Experiences and Self-Gain Among Family Caregivers of Persons With Heart Failure
Bangerter, Lauren R. , Dunlay, Shannon M. , Griffin, Joan M.

Mayo Clinic

The Gerontologist | December 7, 2018 | Volume: 59 | Issue: 5 | Pages: e433-e440

10.1093/geront/gny162 | PMID 30535012 Get It

Abstract Background The majority of aging adults with heart failure (HF) receive support from a family caregiver. Most literature has emphasized the stressors and burden of caregiving, with less focus on positive self-gains associated with caregiving. Methods and Results Using an explanatory sequential design, we assessed self-gain by administering a survey to caregivers of a person with HF (n = 108) and then conducted qualitative semi-structured interviews with a subset (n = 16) of these caregivers. Quantitative results indicate spousal caregivers, and caregivers with higher preparedness and higher mastery had greater odds of reporting high self-gain. Content analysis of qualitative data revealed 3 themes of self-gain including (i) caregiving as a means to enhancing relationships, (ii) success in negotiating care and healthy behaviors with people with HF, and (iii) caregiving as a means of preparing caregivers for the future. Conclusions HF caregivers experience a range of positive self-gains and the ability to find meaning in the stressful caregiving role. Caregivers’ ability to garner intrinsic gains from their role can have important benefits well after caregiving has ended.
TEE-guided transatrial inferior vena cava and hepatic veins thrombectomy during double lung transplantation in a VV ECMO-supported patient
Ahmed, Magdy M. El‐Sayed , Rodrigues, Eduardo , Narula, Tathagat , Thomas, Mathew , Thomas, Mathew , El-Sayed Ahmed, Magdy M , Pham, Si M. , Thomas, Mathew , Renew, J. Ross

Mayo Clinic

Journal of Cardiac Surgery | December 7, 2018 | Volume: 33 | Issue: 12 | Pages: 870-871

10.1111/jocs.13957 | PMID 30525232 Get It

Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop
Schmader, Kenneth E. , Abernethy, Darrell R., Gray, Shelly L. , Dunbar‐Jacob, Jacqueline , Holmes, Holly M. , Murray, Michael D. , Roberts, Robert , Peterson, Josh F. , Lindeman, David , Downey, Laura , Rich, Michael W. , Joyner, Michael, Peterson, Josh F , Schwartz, Janice B. , Hanlon, Joseph T. , Abernethy, Darrell R., Joyner, Michael J. , Tai‐Seale, Ming

Mayo Clinic

Journal of the American Geriatrics Society | December 7, 2018 | Volume: 67 | Issue: 2 | Pages: 371-380

10.1111/jgs.15634 | PMID 30536694 Get It

OBJECTIVES To identify the top priority areas for research to optimize pharmacotherapy in older adults with cardiovascular disease (CVD). DESIGN Consensus meeting. SETTING Multidisciplinary workshop supported by the National Institute on Aging, the American College of Cardiology, and the American Geriatrics Society, February 6–7, 2017. PARTICIPANTS Leaders in the Cardiology and Geriatrics communities, (officers in professional societies, journal editors, clinical trialists, Division chiefs), representatives from the NIA; National Heart, Lung, and Blood Institute; Food and Drug Administration; Centers for Medicare and Medicaid Services, Alliance for Academic Internal Medicine, Patient‐Centered Outcomes Research Institute, Agency for Healthcare Research and Quality, pharmaceutical industry, and trainees and early career faculty with interests in geriatric cardiology. MEASUREMENTS Summary of workshop proceedings and recommendations. RESULTS To better align older adults’ healthcare preferences with their care, research is needed to improve skills in patient engagement and communication. Similarly, to coordinate and meet the needs of older adults with multiple comorbidities encountering multiple healthcare providers and systems, systems and disciplines must be integrated. The lack of data from efficacy trials of CVD medications relevant to the majority of older adults creates uncertainty in determining the risks and benefits of many CVD therapies; thus, developing evidence‐based guidelines for older adults with CVD is a top research priority. Polypharmacy and medication nonadherence lead to poor outcomes in older people, making research on appropriate prescribing and deprescribing to reduce polypharmacy and methods to improve adherence to beneficial therapies a priority. CONCLUSION The needs and circumstances of older adults with CVD differ from those that the current medical system has been designed to meet. Optimizing pharmacotherapy in older adults will require new data from traditional and pragmatic research to determine optimal CVD therapy, reduce polypharmacy, increase adherence, and meet person‐centered goals. Better integration of the multiple systems and disciplines involved in the care of older adults will be essential to implement and disseminate best practices. J Am Geriatr Soc 67:371–380, 2019.
Lipid Membranes: Curvature Elasticity‐Driven Leaflet Asymmetry and Interleaflet Raft Coupling in Supported Membranes (Adv. Mater. Interfaces 23/2018)
Jordan, Luke R. , Kim, Sang Moon , Jeong, Cherlhyun , Warrington, Arthur E. , Lee, Sin‐Doo, Ryu, Yong‐Sang , Wittenberg, Nathan J. , Yoo, Daehan , Rodriguez, Moses , Oh, Sang‐Hyun

Mayo Clinic

Advanced Materials Interfaces | December 7, 2018 | Volume: 5 | Issue: 23 | Pages: No page available

10.1002/admi.201870117 Get It

High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network
Fudim, Marat , Ambrosy, Andrew P. , Sun, Jie‐Lena , Anstrom, Kevin J. , Bart, Bradley A. , Butler, Javed , AbouEzzeddine, Omar F. , Greene, Stephen J. , Mentz, Robert J. , Redfield, Margaret M. , Reddy, Yogesh N.V. , Borlaug, Barry A. , Felker, G. Michael , AbouEzzeddine, Omar, Nishimura, Rick , Borlaug, Barry A , Mentz, Robert J , Vaduganathan, Muthiah , Braunwald, Eugene , Hernandez, Adrian F. , AbouEzzeddine, Omar F

Mayo Clinic

Journal of the American Heart Association | December 7, 2018 | Volume: 7 | Issue: 24 | Pages: No page available

10.1161/jaha.118.010364 | PMID 30561266 Get It

Background We sought to study the prevalence of high‐sensitivity troponin and its association with cardiac structure and outcomes in ambulatory and hospitalized patients with heart failure with a preserved ejection fraction ( HF p EF ). Methods and Results A post hoc analysis utilized data from HF p EF patients: DOSE (Diuretic Optimization Strategies Evaluation) and CARRESS ‐ HF (Cardiorenal Rescue Study in Acute Decompensated Heart Failure) enrolled patients hospitalized with acute HF p EF , and RELAX (Phosphodiesterase‐5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure With Preserved Ejection Fraction) enrolled ambulatory patients with HF p EF . High‐sensitivity troponin I (hs‐TnI) was measured in hospitalized patients at baseline, at 72 to 96 hours, on day 7, and on day 60. In ambulatory patients hs‐TnI was measured at baseline and at week 24. In the ambulatory cohort, correlations between hs‐TnI and cardiac structure and function were assessed. The association between hs‐TnI and a 60‐day composite of emergency room visits, readmissions, and death was assessed for hospitalized patients using multivariable Cox proportional hazard models. The study population included 139 hospitalized and 212 ambulatory patients with HF p EF and hs‐TnI measured at baseline. The median (25th, 75th percentiles) baseline troponin was 17.6 (11.1, 41.0) ng/L in hospitalized patients and 9.5 (5.3, 19.7) ng/L in ambulatory patients ( P <0.001). The prevalence of elevated hs‐TnI (>99% percentile upper reference limit was 86% in hospitalized patients and 53% among ambulatory patients, with stable elevation in ambulatory patients during follow‐up. HF p EF patients with a hs‐TnI above the median were older with worse left ventricular hypertrophy and diastolic dysfunction. Continuously valued hs‐TnI (per doubling) was associated with increased risk of composite end point (adjusted hazard ratio 1.20, 95% confidence interval 1.00‐1.43; P =0.042). Conclusions Hs‐TnI is commonly elevated among both hospitalized and ambulatory patients with HF p EF . Increased hs‐TnI levels are associated with worse cardiac structure and increased risk of adverse events.
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections
Charlton, Carmen , Babady, Esther , Ginocchio, Christine C. , Hatchette, Todd F. , Jerris, Robert C. , Loeffelholz, Mike J., McCarter, Yvette S., Novak-Weekley, Susan, Widen, R, Drews, Steven J. , Babady, N. Esther , Tang, Yi-Wei , Li, Yan , Miller, Melissa B. , Schuetz, Audrey N. , Tang, Yi‐Wei

Mayo Clinic

Clinical Microbiology Reviews | December 7, 2018 | Volume: 32 | Issue: 1 | Pages: No page available

10.1128/cmr.00042-18 | PMID 30541871 Get It

Respiratory viral infections are associated with a wide range of acute syndromes and infectious disease processes in children and adults worldwide. Many viruses are implicated in these infections, and these viruses are spread largely via respiratory means between humans but also occasionally from animals to humans.
Do Tibial Eminence Fractures and Anterior Cruciate Ligament Tears Have Similar Outcomes?
Melugin, Heath P. , Desai, Vishal S. , Milbrandt, Todd A. , Dahm, Diane L., Levy, Bruce A. , Krych, Aaron J. , Krych, Aaron J , Desai, Vishal , Camp, Christopher L. , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | December 7, 2018 | Volume: 6 | Issue: 12 | Pages: No page available

10.1177/2325967118811854 | PMID 30547044 Get It

Background: Avulsion fractures involving the tibial eminence are considered equivalent in terms of the cause to anterior cruciate ligament (ACL) tears; however, there are limited data comparing the outcomes of adolescent patients undergoing surgical fixation of a tibial eminence fracture (TEF) with those undergoing ACL reconstruction. Purpose: To compare the clinical outcomes, subsequent ACL injury rates, and activity levels between adolescent patients who underwent TEF fixation with patients with midsubstance ACL tears who required acute reconstruction. Study Design: Cohort study; Level of evidence, 3. Methods: This study included a group of patients with TEFs treated with surgical fixation matched to a group of similar patients with ACL tears treated with reconstruction between the years 2001 and 2015. Data regarding the initial injury, surgical intervention, ACL/ACL graft injury rates, and physical examination findings were recorded. Clinical and functional outcomes were obtained using a physical examination, the International Knee Documentation Committee (IKDC) subjective score, the Lysholm score, and the Tegner activity score. Results: Sixty patients with a mean follow-up of 57.7 months (range, 24-206 months) were included; 20 patients (11 male, 9 female; mean age, 11.9 years [range, 7-15 years]) who underwent surgical fixation for a TEF were matched to a group of 40 patients (23 male, 17 female; mean age, 12.5 years [range, 8-5 years]) who underwent reconstruction for ACL tears. The TEF group demonstrated significantly lower postoperative IKDC scores (TEF group, 94.0; ACL group, 97.2; P = .04) and Lysholm scores (TEF group, 92.4; ACL group, 96.9; P = .02). The TEF group returned to sport 119 days sooner ( P < .01), but there was no difference in postoperative Tegner scores (TEF group, 7.3; ACL group, 7.6; P = .16). The TEF group demonstrated increased postoperative anterior laxity ( P = .02) and a higher rate of postoperative arthrofibrosis ( P = .04). There was no difference in subsequent ACL injuries ( P = .41). Conclusion: Both groups demonstrated quality outcomes at a minimum 2-year follow-up. Patients with TEFs demonstrated lower mean clinical outcome scores compared with patients with ACL tears, but the differences were less than reported minimal clinically important difference values. Additionally, the TEF group experienced more postoperative anterior laxity and had a higher rate of postoperative arthrofibrosis. There was no difference in the rate of subsequent ACL injuries. The TEF group returned to sport sooner than the ACL group, but the postoperative activity levels were similar.
Desmoplastic Small Round Cell Tumors With Atypical Presentations: A Report of 34 Cases
Al‐Ibraheemi, Alyaa , Broehm, Cory , Tanas, Munir R. , Horvai, Andrew , Cheah, Alison L., Thway, Khin , Fisher, Cyril , Bahrami, Armita , Folpe, Andrew L. , Fritchie, Karen , Thway, Khin , Fritchie, Karen J. , Rubin, Brian P.

Mayo Clinic

International Journal of Surgical Pathology | December 7, 2018 | Volume: 27 | Issue: 3 | Pages: 236-243

10.1177/1066896918817140 | PMID 30522375 Get It

Objectives. Desmoplastic small round cell tumor (DSRCT) is an aggressive round cell sarcoma that arises in the abdominal cavity/pelvis of young males. We sought to expand its clinicopathologic spectrum. Methods. Cases of DSRCT presenting in patients >30 years of age or tumors arising outside of the abdominal cavity/pelvis were retrieved. Results. Thirty-four cases were identified. Sixteen tumors arose at atypical sites (head/neck, intracranial, thigh, axilla/shoulder, inguinal/paratesticular, intraosseous, and uterine corpus). The remaining 18 patients were older than 30 years, and their tumors involved the abdomen or pelvis. The majority of cases showed areas with classic histology, while 6 cases exhibited solid growth and 5 showed macronodular architecture. Cytologic appearance included round cell, rhabdoid, epithelioid, and small cell. Conclusion. DSRCT may arise at nonabdominal locations in both pediatric and adult populations, as well as intra-abdominally in older adults, and these tumors exhibit high rates of metastasis and morbidity.
FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy
O’Neill, Brian T. , Penniman, Christie M., Krumpoch, Megan, Beltran, Pablo A. Suarez, Klaus, Katherine A. , Poro, Kennedy, Pan, Hui , Klaus, Katherine, Kahn, C Ronald , Bhardwaj, Gourav , Li, Mengyao , Pan, Hui , Dreyfuss, Jonathan M. , Nair, K. Sreekumaran

Mayo Clinic

Diabetes | December 6, 2018 | Volume: 68 | Issue: 3 | Pages: 556-570

10.2337/db18-0416 | PMID 30523026 Get It

Insulin deficiency and uncontrolled diabetes lead to a catabolic state with decreased muscle strength, contributing to disease-related morbidity. FoxO transcription factors are suppressed by insulin and thus are key mediators of insulin action. To study their role in diabetic muscle wasting, we created mice with muscle-specific triple knockout of FoxO1/3/4 and induced diabetes in these M-FoxO-TKO mice with streptozotocin (STZ). Muscle mass and myofiber area were decreased 20–30% in STZ-Diabetes mice due to increased ubiquitin-proteasome degradation and autophagy alterations, characterized by increased LC3-containing vesicles, and elevated levels of phosphorylated ULK1 and LC3-II. Both the muscle loss and markers of increased degradation/autophagy were completely prevented in STZ FoxO-TKO mice. Transcriptomic analyses revealed FoxO-dependent increases in ubiquitin-mediated proteolysis pathways in STZ-Diabetes, including regulation of Fbxo32 (Atrogin1), Trim63 (MuRF1), Bnip3L, and Gabarapl. These same genes were increased 1.4- to 3.3-fold in muscle from humans with type 1 diabetes after short-term insulin deprivation. Thus, FoxO-regulated genes play a rate-limiting role in increased protein degradation and muscle atrophy in insulin-deficient diabetes.
Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohorts
McCreary, Morgan , Mealy, Maureen A. , Wingerchuk, DM, Levy, Michael , DeSena, Allen D., Greenberg, Benjamin , McCreary, M , Mealy, M A , Levy, Michael , Greenberg, Benjamin M

Mayo Clinic

Multiple Sclerosis Journal - Experimental, Translational and Clinical | December 6, 2018 | Volume: 4 | Issue: 4 | Pages: No page available

10.1177/2055217318815925 | PMID 30559975 Get It

Background The specificity of the aquaporin-4 antibody to predict recurrent inflammatory central nervous system disease has led to the design of the 2015 neuromyelitis optica spectrum disorder criteria which capture all aquaporin-4 antibody seropositive patients. Objective The purpose of this study was to compare treatment outcomes in aquaporin-4 antibody seropositive patients who met the previous 2006 clinical criteria for neuromyelitis optica with patients who meet the 2015 neuromyelitis optica spectrum disorder criteria. Methods The study involved a three-center retrospective chart review of clinical outcomes among aquaporin-4 patients diagnosed with neuromyelitis optica and neuromyelitis optica spectrum disorder. Results Hazard ratios of relapse during immunosuppressive therapy, relative to pre-therapy, were not significantly different for patients who met the 2006 criteria of neuromyelitis optica versus the 2015 neuromyelitis optica spectrum disorder criteria among those treated with azathioprine ( p = 0.24), mycophenolate mofetil ( p = 0.63), or rituximab ( p = 0.97). Conclusion Reductions in the hazard of relapse during treatment with immunosuppressive therapies, relative to average pre-treatment, were not different for aquaporin-4 antibody seropositive patients categorized using the 2006 criteria of neuromyelitis optica and the 2015 neuromyelitis optica spectrum disorder criteria. These therapeutic findings support the design of the 2015 neuromyelitis optica spectrum disorder criteria which capture all aquaporin-4 antibody seropositive patients.